CTSA Renewal Celebration

From left: Jonathan Holloway, President, Rutgers University; Mark Manigan, CEO, RWJBarnabas Health; Brian Strom, Chancellor, Rutgers Health; Governor Phil Murphy; Shawna Hudson, Vice Chancellor for Translational Medicine and Science Director, Rutgers Health; Reynold Panettieri, Vice Chancellor for Translational Medicine and Science, Rutgers Health. Photo: Luca Mostello

NJ ACTS Receives 7-year Grant Renewal of $39.7M

Translating scientific discoveries  into improved health in New Jersey and beyond 

 

Join Our Clinical Research Investigator Registry

The Registry can match investigators with new clinical trial opportunities!

 

Advancing clinical and translational science to develop new therapies and treatments and improve health care

Become a Member

NJ ACTS is dedicated to leading the development of new approaches to the health problems of New Jersey and to translating those advances into therapies and treatments.

Find a Clinical Trial

Rutgers supports nearly 350 clinical trials at any given time. Our Rutgers Clinical Research Organization is the gateway to our statewide clinical trial activities

Funding Opportunities

NJ ACTS disseminates information on funding opportunities to its members and partner institutions, directly through emails and our website.

NJ ACTS Services & SRB

NJ ACTS Cores offer consulting, tools and other services to its members and partner institutions.

EVENTS


NEWS


What Can Ice Worms Reveal About the Human Body?

What Can Ice Worms Reveal About the Human Body?

Deep within the icy stillness of the glaciers and snowfields found across Alaska, British Columbia, and the Pacific Northwest lives a scientific marvel that could hold the key to life-saving breakthroughs in medicine and health: the Mesenchytras solifugus, more...

VIDEO HIGHLIGHTS

Dr. Reynold Panettieri on "What to know about the next generation of COVID-19 vaccines"